secwatch.observer — SEC 8-K summary
======================================

Issuer:     RenovoRx, Inc. (RNXT)
CIK:        0001574094
Form:       8-K
Filed at:   2026-06-30T20:55:23+00:00
Accession:  0001493152-26-031303
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RenovoRx stockholders elect directors, approve equity plan amendment, ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected with 12.9M+ votes for each; broker non-votes of 9.6M.
- Amendment to 2021 Omnibus Equity Incentive Plan approved: 9.7M for, 3.6M against; adds 2,000,000 shares (4.4% of outstanding).
- Ratification of Frank, Rimerman + Co. LLP as auditor for FY 2026: 21.9M for, 477k against.
- Approximately 22.8M shares (50.6% of 45.1M outstanding) present or represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574094/000149315226031303/0001493152-26-031303-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574094/000149315226031303/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-031303

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer